Insight Holdings Group Sells $121.5M in Hinge Health Stock Under 10b5-1 Plan
HNGE has more than doubled off its 52-week low of $30.08 on elevated volume (2.6× avg).
Summary
A major institutional investor, Insight Holdings Group, sold $121.5 million worth of Hinge Health stock through a pre-planned 10b5-1 trading plan, significantly reducing its stake.
Key Events · Ownership and Investor Activity · HNGE
-
Major Institutional Investor Sale
Insight Holdings Group, a 10% owner, sold $121,489,333 worth of Class A Common Stock.
-
Significant Stake Reduction
The sale represents 3.85% of Hinge Health's market capitalization and approximately 31.3% of the reporting owners' prior holdings.
-
Pre-Planned Transaction
The sales were executed under a Rule 10b5-1 trading plan adopted on August 20, 2025.
-
Class B to Class A Conversion
Prior to the sale, the reporting persons converted 1,466,667 shares of Class B Common Stock into Class A Common Stock.
Analysis · HNGE · Technology
Insight Holdings Group, a 10% owner, executed a substantial sale of Hinge Health stock totaling $121.5 million. While this transaction was pre-planned under a Rule 10b5-1 plan, reducing the immediate signal of new bearish sentiment, the sheer magnitude of the sale (representing 3.85% of the company's market capitalization and over 31% of the investor's prior holdings) is significant. This divestment, occurring near the stock's 52-week high, suggests the institutional investor is locking in gains and reducing its exposure, which can create selling pressure on the stock.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 30.9% of the 1649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HNGE was trading at $82.53 on NYSE in the Technology sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $30.08 to $84.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.